Valley Childrens Hospital
- Type
- Teaching hospital
- Where
- Madera, CA
- Medicare CCN
- 053300
- Received
- $129,848 in 27 records, 2024 ($22,422 general, $107,425 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit: VALLEY CHILDRENS HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 17 | $22,422 |
| 2024 | Research payment | 10 | $107,425 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $40,396 | 2024 |
| Genentech, Inc. | 2 | $22,116 | 2024 |
| HEMA Biologics, LLC | 2 | $16,975 | 2024 |
| PFIZER INC. | 3 | $15,650 | 2024 |
| JAZZ PHARMACEUTICALS INC. | 3 | $11,100 | 2024 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $9,500 | 2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $4,788 | 2024 |
| Smith+Nephew, Inc. | 1 | $2,669 | 2024 |
| NS Pharma, Inc. | 1 | $1,500 | 2024 |
| Sarepta Therapeutics, Inc. | 1 | $1,500 | 2024 |
| Incyte Corporation | 1 | $1,000 | 2024 |
| Fisher Scientific Company L.L.C. | 1 | $758 | 2024 |
| KARL STORZ Endoscopy-America | 2 | $592 | 2024 |
| Mallinckrodt Hospital Products Inc. | 1 | $514 | 2024 |
| Monaghan Medical Corporation | 1 | $500 | 2024 |
| Siemens Medical Solutions USA, Inc. | 1 | $179 | 2024 |
| Stryker Corporation | 2 | $108 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 10 | $107,425 |
| Grant | 6 | $13,000 |
| Debt forgiveness | 5 | $3,764 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $3,500 |
| Space rental or facility fees (teaching hospital only) | 4 | $2,114 |
| Long term medical supply or device loan | 1 | $44 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Siemens Medical Solutions USA, Inc. | $179 | Debt forgiveness | In-kind items and services | 2024 | ||
| 2024-12-31 | Stryker Corporation | $63 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-12-31 | Stryker Corporation | $44 | Long term medical supply or device loan | In-kind items and services | Precision IE 4K Device, ENDOSCOPY | 2024 | |
| 2024-09-27 | KARL STORZ Endoscopy-America | $500 | Grant | Cash or cash equivalent | C-MAC Device, ANESTHESIOLOGY | 2024 | |
| 2024-09-06 | Smith+Nephew, Inc. | $2,669 | Debt forgiveness | Cash or cash equivalent | Device, Sports Med Shoulder | 2024 | |
| 2024-08-23 | Fisher Scientific Company L.L.C. | $758 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-08-08 | Monaghan Medical Corporation | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | AeroChamber Device, Chamber | 2024 | |
| 2024-08-02 | Mallinckrodt Hospital Products Inc. | $514 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | INOMAX Drug, CRITICAL CARE | 2024 | |
| 2024-07-24 | JAZZ PHARMACEUTICALS INC. | $10,000 | Research payment | Cash or cash equivalent | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) | 2024 |
| 2024-07-03 | Incyte Corporation | $1,000 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2024 | |
| 2024-06-26 | Genentech, Inc. | $2,700 | Research payment | Cash or cash equivalent | Evrysdi Drug, Neurology | LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT | 2024 |
| 2024-06-19 | Genentech, Inc. | $19,416 | Research payment | Cash or cash equivalent | Evrysdi Drug, Neurology | LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT | 2024 |
| 2024-05-24 | CATALYST PHARMACEUTICALS, INC. | $3,000 | Grant | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2024 | |
| 2024-05-08 | PFIZER INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-05-01 | JAZZ PHARMACEUTICALS INC. | $600 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-04-29 | PFIZER INC. | $9,500 | Research payment | Cash or cash equivalent | LOW INTERVENTIONAL COHORT STUDY OF MYOCARDITISPERICARDITIS ASSOCIATED WITH COMIRNATY IN PERSONS LESS THAN 21 YEARS OF AG | 2024 | |
| 2024-04-26 | JAZZ PHARMACEUTICALS INC. | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-04-21 | KARL STORZ Endoscopy-America | $92 | Debt forgiveness | In-kind items and services | 2024 | ||
| 2024-04-19 | CATALYST PHARMACEUTICALS, INC. | $5,000 | Grant | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2024 | |
| 2024-04-19 | CATALYST PHARMACEUTICALS, INC. | $1,500 | Grant | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2024 | |
| 2024-04-03 | HEMA Biologics, LLC | $9,500 | Research payment | Cash or cash equivalent | SevenFact Biological, Hematology | Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT | 2024 |
| 2024-04-03 | HEMA Biologics, LLC | $7,475 | Research payment | Cash or cash equivalent | SevenFact Biological, Hematology | Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT | 2024 |
| 2024-03-30 | VERTEX PHARMACEUTICALS INCORPORATED | $4,788 | Research payment | Cash or cash equivalent | A Non-Interventional Study Evaluating the Impact of TRIKAFTA Initiation on 2- to 5-Year-Olds With Cystic Fibrosis and Th | 2024 | |
| 2024-02-29 | Sarepta Therapeutics, Inc. | $1,500 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-02-28 | NS Pharma, Inc. | $1,500 | Grant | Cash or cash equivalent | VILTEPSO Drug, PEDIATRIC NEUROLOGY | 2024 | |
| 2024-02-21 | Novartis Pharmaceuticals Corporation | $40,396 | Research payment | Cash or cash equivalent | ZOLGENSMA Drug, Neurology | A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy | 2024 |
| 2024-01-29 | PFIZER INC. | $2,650 | Research payment | Cash or cash equivalent | LOW INTERVENTIONAL COHORT STUDY OF MYOCARDITISPERICARDITIS ASSOCIATED WITH COMIRNATY IN PERSONS LESS THAN 21 YEARS OF AG | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Madera, CA, county Madera County, CA, state California; placed by its city name.
| Measure | Place (city or town) Madera, CA | County Madera County, CA | State California |
|---|---|---|---|
| Population B01003 | 67,831 | 160,940 | 39,287,377 |
| Population, 2020 census P1 | 66,224 | 156,255 | 39,538,223 |
| Median age B01002 | 30.4 | 34.6 | 37.9 |
| Under 18 B01001 | 30.8% | 27.1% | 22.0% |
| 65 and over B01001 | 9.6% | 14.4% | 15.7% |
| Households B11001 | 17,526 | 45,379 | 13,548,091 |
| Foreign born B05002 | 25.6% | 20.1% | 27.0% |
| Median household income B19013 | $63,933 | $76,627 | $99,122 |
| Median family income B19113 | $67,479 | $83,389 | $113,346 |
| Per capita income B19301 | $24,200 | $30,077 | $49,513 |
| Poverty rate B17001 | 25.6% | 19.2% | 12.0% |
| Unemployment rate B23025 | 12.6% | 10.1% | 6.6% |
| Civilian labor force B23025 | 29,997 | 69,012 | 20,068,466 |
| Mean commute (minutes) B08013 | 25.7 | 27.9 | 28.7 |
| Bachelor's degree or higher B15003 | 10.9% | 17.9% | 37.1% |
| Housing units B25001 | 18,562 | 51,015 | 14,644,735 |
| Owner-occupied B25003 | 54.7% | 67.5% | 55.9% |
| Renters B25003 | 45.3% | 32.5% | 44.1% |
| Median home value B25077 | $359,900 | $393,200 | $734,700 |
| Median gross rent B25064 | $1,353 | $1,390 | $2,036 |
| White, not Hispanic B03002 | 12.2% | 29.9% | 33.8% |
| Black B03002 | 2.9% | 2.4% | 5.2% |
| Hispanic or Latino B03002 | 81.1% | 60.9% | 40.2% |
| Asian B03002 | 1.3% | 2.4% | 15.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.4% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Madera, CA.
Comments